RMC-GI-102: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors (clinicaltrials.gov) - Sep 23, 2026 - P1/2 | N=1130 | Recruiting | Sponsor: Revolution Medicines, Inc. | Trial completion date: Jul 2027 ➔ Mar 2030 | Trial primary completion date: May 2027 ➔ Sep 2028
Trial completion date • Trial primary completion date • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Solid Tumor • RAS
|